explained to us that allergan has not just one new drug, but the possibility of a second blockbuster, an inhaled migraine fighter that his company now owns 100% of thanks to the pending purchase of mac pharmaceuticals. well, the interview broke no news, kind of like, you know, breaking news thing, it did produce something i felt that was better. a more pertinent impression, which was that pyatt's allergan's ever conservative ceo. always really conservative. when i said if i read the tea leaves right, the fact he guided analysts higher, not lower this time meant he was more bullish than usual. his readiness to agree with that. this is a conservative guy. the readiness gave you a fabulous trade. allergan went to 108 1/2 as it should have. you can hold on to up here, but $1.50 is a good day's work, depending on how much capital you put to work. while i was doing interviews, you got news out of chipotle. seemed like a not so hot less than 4% same-store sales. we used to get double-digit same store sales. you know i've been waiting for chipotle to increase the prices on its menus, they ha